Taiwan Bio’s SuperCarrier MSC is a cutting-edge, genetically engineered cell therapy with an unparalleled growth factor or cytokine secretion ability.
MSC-VEGF: our first SuperCarrier MSC
Improving angiogenesis and restoring local blood flow to
treat ischaemic diseases
MSC-VEGF: our first SuperCarrier MSC
Improving angiogenesis and restoring local blood flow to treat ischaemic diseases
Our portfolio
We aim to bring new hope to patients with our novel
platform technologies and creative approaches
Pipeline
MSC_VEGF
Critical limb ischemia｜Genetic engineered
TBPCB201
Acute myocardial infarction | Precision cell bank
Biochymal
Unhealed wound caused by CLI | Hypoxia-preconditioned
Chondrochymal
OA | Hypoxia-preconditioned
Our portfolio
We aim to bring new hope to patients with our novel platform technologies and creative approaches
Pipeline
MSC_VEGF
Critical limb ischemia｜Genetic engineered
TWB201
Acute myocardial infarction | Precision cell bank
Biochymal
Unhealed wound caused by CLI | Hypoxia-preconditioned
Chondrochymal
OA | Hypoxia-preconditioned